Evidence map›Paper›PMID 19053285›Full record

ArticleBiochemistry2008

Structural basis of substrate recognition by hematopoietic tyrosine phosphatase.

David A Critton, Antoni Tortajada, Geoffrey Stetson, Wolfgang Peti, Rebecca Page

Abstract readComparative Study
In one paragraph

Article in Biochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. The interaction of p38 with its upstream kinase MKK6.Protein science : a publication of the Protein Society · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Molecular basis of MAP kinase regulation.Protein science : a publication of the Protein Society · 2013
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Resting and active states of the ERK2:HePTP complex.Journal of the American Chemical Society · 2011
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

David A CrittonDepartment of Molecular Biology, Brown University, Providence, Rhode Island 02912, USA.
Antoni Tortajada
Geoffrey Stetson
Wolfgang Peti
Rebecca Page
Brown University · US

Funding

UNDERGRADUATE RESEARCH AND SEMINARSP20RR016457 · NCRR · UNIVERSITY OF RHODE ISLAND · PI SHAKARIAN, ALISON M · 2001 to 2011
$35.5M
An 800 MHz NMR spectrometer for the Boston areaS10RR017269 · NCRR · BRANDEIS UNIVERSITY · PI POCHAPSKY, THOMAS CHARLES · 2003 to 2003
$2.0M
NCRR NIH HHS P20 RR016457NCRR NIH HHS P 20 RR16457NCRR NIH HHS S10 RR017269NCRR NIH HHS S10-RR017269NIGMS NIH HHS Y01 GM000080
6 · The paper itself

Abstract

Hematopoietic tyrosine phosphatase (HePTP) is one of three members of the kinase interaction motif (KIM) phosphatase family which also includes STEP and PCPTP1. The KIM-PTPs are characterized by a 15 residue sequence, the KIM, which confers specific high-affinity binding to their only known substrates, the MAP kinases Erk and p38, an interaction which is critical for their ability to regulate processes such as T cell differentiation (HePTP) and neuronal signaling (STEP). The KIM-PTPs are also characterized by a unique set of residues in their PTP substrate binding loops, where 4 of the 13 residues are differentially conserved among the KIM-PTPs as compared to more than 30 other class I PTPs. One of these residues, T106 in HePTP, is either an aspartate or asparagine in nearly every other PTP. Using multiple techniques, we investigate the role of these KIM-PTP specific residues in order to elucidate the molecular basis of substrate recognition by HePTP. First, we used NMR spectroscopy to show that Erk2-derived peptides interact specifically with HePTP at the active site. Next, to reveal the molecular details of this interaction, we solved the high-resolution three-dimensional structures of two distinct HePTP-Erk2 peptide complexes. Strikingly, we were only able to obtain crystals of these transient complexes using a KIM-PTP specific substrate-trapping mutant, in which the KIM-PTP specific residue T106 was mutated to an aspartic acid (T106D). The introduced aspartate side chain facilitates the coordination of the bound peptides, thereby stabilizing the active dephosphorylation complex. These structures establish the essential role of HePTP T106 in restricting HePTP specificity to only those substrates which are able to interact with KIM-PTPs via the KIM (e.g., Erk2, p38). Finally, we describe how this interaction of the KIM is sufficient for overcoming the otherwise weak interaction at the active site of KIM-PTPs.

Indexed as

Amino Acid MotifsAmino Acid SequenceCatalytic DomainConserved SequenceCrystallography, X-RayHematopoiesisHumansMolecular Sequence DataMutagenesis, Site-DirectedPhosphorylationProtein ConformationProtein Tyrosine Phosphatases, Non-ReceptorSubstrate SpecificityProtein Tyrosine Phosphatases, Non-ReceptorPTPN7 protein, human

Identifiers

PMID19053285
PMCPMC2908255
OpenAlexW2087147338

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.